EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort

Mengqi Wu, Xin Zhou, Saiping Chen, Yuqing Wang, Bin Lu, Aiping Zhang, Yanqin Zhu, Min Huang, Jiarui Wang, Junyi Liu, Fenggui Zhu, Hong Liu und 1 weitere

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1606700 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Mengqi Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hangzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetic Nephropathies, Bacteria. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Traditional Chinese Medicine Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic kidney disease (DKD) exhibits heterogeneous progression, implicating factors beyond hyperglycemia, such as gut microbiota dysbiosis. However, microbial distinctions among biopsy-confirmed pure DKD, DKD with non-diabetic renal disease (DKD+NDRD), and long-term diabetes without nephropathy (DM) remain unclear. This study aimed to identify gut microbial and functional biomarkers differentiating these groups.

Methods

We enrolled 40 biopsy-confirmed participants classified into DKD (n=26), DM (n=8), and DKD+NDRD (n=6) groups. Gut microbiota was profiled using 16S rRNA sequencing. Microbial diversity, composition, and functional prediction (PICRUSt2 analysis) were compared among groups. Biomarkers were identified using LEfSe analysis.

Results

No significant differences in alpha-diversity (Chao1, Shannon indices) or beta-diversity (PCoA/PCA) were observed among groups. Taxonomic analysis revealed distinct microbial signatures: DKD patients showed enrichment of Olsenella and reduced Faecalibacterium prausnitzii (a short-chain fatty acid producer), while DM patients exhibited higher Roseburia and Flavonifractor. The DKD+NDRD group was uniquely enriched in Prevotella_9. Functional prediction highlighted elevated pyruvate metabolism and bacterial toxin pathways in DKD, contrasting with enhanced linoleic acid metabolism in DM and attenuated endotoxin-related pathways in DKD+NDRD.

Conclusions

This study delineates gut microbiota profiles and functional shifts across DKD, DM, and DKD+NDRD. Key taxa (Olsenella, Prevotella_9) and metabolic pathways (pyruvate, toxin production) may serve as biomarkers for DKD progression and differential diagnosis. The findings underscore the gut-kidney axis’s role in DKD pathogenesis and suggest microbiota-targeted interventions for precision management. Further validation in larger cohorts is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiabetic NephropathiesBacteriaHumansMaleMiddle AgedFemaleRNA, Ribosomal, 16SBiomarkersAgedCohort StudiesDysbiosisAdultFecesDNA, Bacterial

Stichwörter der Autor:innen

16S rRNAdiabetic kidney disease (DKD)disease progressiongut microbiotaintestinal biomarker

Substanzen

RNA, Ribosomal, 16SBiomarkersDNA, Bacterial

Autor:innen und Institutionen

  • Department of Nephrology, Hangzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Department of General Medicine, Tianshui Wulin Street Community Heal Care Centre, Hangzhou, Zhejiang, China.
  • Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, Zhejiang, China.

Förderung

  • Zhejiang Traditional Chinese Medicine Administration

Zitieren

APA

Wu, M., Zhou, X., Chen, S., Wang, Y., Lu, B., Zhang, A., Zhu, Y., Huang, M., Wang, J., Liu, J., Zhu, F., Liu, H., & Lin, R. (2025). The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1606700

Vancouver

Wu M, Zhou X, Chen S, Wang Y, Lu B, Zhang A, et al. The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1606700

BibTeX
@article{Wu2025,
  author = {Wu, Mengqi and Zhou, Xin and Chen, Saiping and Wang, Yuqing and Lu, Bin and Zhang, Aiping and Zhu, Yanqin and Huang, Min and Wang, Jiarui and Liu, Junyi and Zhu, Fenggui and Liu, Hong and Lin, Riyang},
  title = {The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1606700}
}
Kostenlos starten →